São Paulo

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma1 trial
• Lupus (SLE)1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Celgene1 trial
• Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Running trials

• Active, not recruiting

  A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

  NCT07015983· Phase 2· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

  NCT06425302· Phase 2· Celgene· Source